A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

NCT05121350 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Anlotinib hydrochloride capsule
DRUG: Epirubicin
DRUG: Arotinib hydrochloride capsule placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.